Tone mix
Week by week 51 weeks
Share of Q32 Bio Inc. Common Stock's 118 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jun 24, 2024 · tone -99Q32 Bio Inc.'s (NASDAQ:QTTB) last week's 15% decline must have disappointed private equity firms who have a significant stake-116
- Week of Oct 20, 2025 · tone -99Wall Street Zen Downgrades Q32 Bio (NASDAQ:QTTB) to Sell-99
- Week of Apr 14, 2025 · tone +100Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata+71
- Week of Dec 23, 2024 · tone +36Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Price Target from Brokerages+69
- Week of Sep 23, 2024 · tone -50Q32 Bio (NASDAQ:QTTB) Trading Down 3.7%-64
- Week of Oct 21, 2024 · tone +90Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Raymond James+64
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Q32 Bio Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | +100 |
| Last 30 sessions | 10 | +10 |
| Last 90 sessions | 32 | +25 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletQ32 Bio Inc. (NASDAQ:QTTB) Stock Rated "Moderate Buy" by Wall Street AnalystsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Q32 Bio Inc. (NASDAQ:QTTB) Stock Rated "Moderate Buy" by Wall Street Analysts | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletResearch Analysts' Recent Ratings Updates for Q32 Bio (QTTB)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Research Analysts' Recent Ratings Updates for Q32 Bio (QTTB) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletHead to Head Review: Q32 Bio (NASDAQ:QTTB) vs. Applied Therapeutics (NASDAQ:APLT)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Review: Q32 Bio (NASDAQ:QTTB) vs. Applied Therapeutics (NASDAQ:APLT) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletHead to Head Review: Kyntra Bio (NASDAQ:KYNB) and Q32 Bio (NASDAQ:QTTB)Neutral
- www.dailypolitical.com · 1 outletContrasting Q32 Bio (NASDAQ:QTTB) and Kyntra Bio (NASDAQ:KYNB)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Review: Kyntra Bio (NASDAQ:KYNB) and Q32 Bio (NASDAQ:QTTB) | www.tickerreport.com | 1 | Neutral |
| Contrasting Q32 Bio (NASDAQ:QTTB) and Kyntra Bio (NASDAQ:KYNB) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletFinancial Analysis: Q32 Bio (NASDAQ:QTTB) versus Legend Biotech (NASDAQ:LEGN)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Analysis: Q32 Bio (NASDAQ:QTTB) versus Legend Biotech (NASDAQ:LEGN) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Q32 Bio Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.